Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751309 · ClinicalTrials.gov registry record
Lung Allograft Rejection Gene Expression Observational (LARGO) Study
A clinical trial, sponsored by XDx.
- Terminated
- Registry status
- 2,044
- Enrollment target
NCT00751309: Clinical Trial study, sponsored by XDx.
NCT00751309 is a clinical trial that was terminated before completion, run by XDx. The registered enrollment target is 2,044 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00751309 was terminated before completion, sponsored by XDx.
- TERMINATED
- Registry status
- 2,044 participants
- Enrollment target
Study Summary
The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perform molecular analyses in association with the study endpoints. The primary objective is to use gene expression profiling of peripheral blood mononuclear cells to differentiate between the absence and presence of acute cellular rejection. The secondary objectives are to use other genomic and proteomic technologies to analyze RNA and protein in blood samples in relation to related clinical conditions. The overall goal is to apply novel molecular insights in the development of non-invasive molecular diagnostic tests for lung transplantation.
Interventions
- OTHER Non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,044 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-01 |
Why NCT00751309 stopped before completion
NCT00751309 is an observational study that tracks outcomes without assigning an intervention. Its 2,044 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional is the first listed.
NCT00751309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00751309 about?
NCT00751309 is a clinical study titled "Lung Allograft Rejection Gene Expression Observational (LARGO) Study". The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perform molecular analyses in association with the study endpoints. The primary objective is to use gene expression p...
What is the current status of trial NCT00751309?
This trial is currently terminated. The enrollment target is 2,044 participants. The study started on 2004-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00751309?
The interventions under investigation include: Non-interventional (OTHER).
Who is sponsoring clinical trial NCT00751309?
This trial is sponsored by XDx, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia